Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma

Published:2016-08 Issue:2 Volume:65 Page:289-295
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Abou-Alfa Ghassan K.,Puig Oscar,Daniele Bruno,Kudo Masatoshi,Merle Philippe,Park Joong-Won,Ross Paul,Peron Jean-Marie,Ebert Oliver,Chan Stephen,Poon Tung Ping,Colombo Massimo,Okusaka Takuji,Ryoo Baek-Yeol,Minguez Beatriz,Tanaka Takayoshi,Ohtomo Toshihiko,Ukrainskyj Stacey,Boisserie Frederic,Rutman Olga,Chen Ya-Chi,Xu Chao,Shochat Eliezer,Jukofsky Lori,Reis Bernhard,Chen Gong,Di Laurenzio Laura,Lee Ray,Yen Chia-Jui

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest;Farooq;Mol Cells,2003

2. Expression of OCI-5/glypican 3 during intestinal morphogenesis: regulation by cell shape in intestinal epithelial cells;Li;Exp Cell Res,1997

3. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma;Capurro;Gastroenterology,2003

4. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules;Libbrecht;Am J Surg Pathol,2006

5. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis;Llovet;Gastroenterology,2006

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map;Clinical Epidemiology;2023-11

2. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy;Cell Biology and Toxicology;2023-10-19

3. A novel bispecific antibody as an immunotherapeutic agent in hepatocellular carcinoma;Molecular Immunology;2023-10

4. Potential Oncotherapeutic Effects of Nutraceuticals against Hepatocellular Carcinoma: Recent Advancements;Current Functional Foods;2023-09

5. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making;Hepatology;2023-06-12